Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
The Korean Journal of Helicobacter and Upper Gastrointestinal Research ; : 160-165, 2015.
Artículo en Coreano | WPRIM | ID: wpr-179131

RESUMEN

BACKGROUND/AIMS: The eradication rates of Helicobacter pylori has been decreasing over the years and it is different among the regions. The aim of this study was to investigate the rates of first-line and the second-line eradication of H. pylori over the last 5 years in a single institute of Changwon and Gyeongsangnam-do, Korea. MATERIALS AND METHODS: Eradication rates of first-line triple regimen in 1,164 patients and second-line quadruple regimen in 223 patients who received H. pylori eradication treatment from January 2008 to December 2012 at Changwon Fatima Hospital were evaluated retrospectively. The patients for second-line quadruple therapy were divided into three groups according to the dosage of medications. RESULTS: The overall eradication rates of first-line and second-line therapy were 70.5% and 81.2%, respectively. There was no decreasing tendency in the eradication rate of first-line therapy for 5 years (P=0.573). However, annul eradication rates of second-line therapy significantly decreased (P=0.001, linear by linear association). In second-line therapy, patients treated with high dose bismuth and metronidazole had higher eradication rates than those treated with low dose bismuth and metronidazole (P=0.039). CONCLUSIONS: The effectiveness of the first-line and second-line therapy for H. pylori was suboptimal. In addition, there was a decreasing tendency in the eradication rates of second-line therapy over the past 5 years in Changwon and Gyeongsangnam-do province. Alternative regimens or high dose therapy should be considered for first-line and second-line therapy.


Asunto(s)
Humanos , Bismuto , Helicobacter pylori , Helicobacter , Corea (Geográfico) , Metronidazol , Estudios Retrospectivos
2.
Yeungnam University Journal of Medicine ; : 38-41, 2015.
Artículo en Coreano | WPRIM | ID: wpr-28201

RESUMEN

Pyogenic liver abscess with metastatic septic complications is a rare and serious infectious disease if not treated properly. Pyogenic liver abscesses are caused by bacterial, fungal, or parasitic organisms. Escherichia coli used to be the predominant causative agent, but Klebsiella pneumoniae emerged as a major cause in the 1990s. Liver abscesses are caused by hepatic invasion via many routes, such as, the biliary tree, portal vein, hepatic artery, direct extension, or penetrating trauma. Furthermore, diabetes mellitus and malignant conditions are established important risk factors of K. pneumoniae liver abscesses and of septic metastasis, and several recent studies have asserted that K. pneumoniae liver abscess might be a presentation of occult or silent colon cancer. We report a case of K. pneumoniae liver abscess, metastatic septic pulmonary embolism, and endophthalmitis associated with diabetes and advanced gastric cancer.


Asunto(s)
Sistema Biliar , Neoplasias del Colon , Enfermedades Transmisibles , Diabetes Mellitus , Endoftalmitis , Escherichia coli , Arteria Hepática , Klebsiella pneumoniae , Absceso Hepático , Absceso Piógeno Hepático , Metástasis de la Neoplasia , Neumonía , Vena Porta , Embolia Pulmonar , Factores de Riesgo , Neoplasias Gástricas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA